Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells.
about
CIViC databaseCetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc.Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.Elevated Syndecan-1 levels in the sera of patients with breast cancer correlate with tumor size.Different patterns of expression of cell cycle control and local invasion-related proteins in oral squamous cell carcinoma affecting young patients.
P2860
Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Epidermal growth factor is a p ...... sponse in tongue cancer cells.
@ast
Epidermal growth factor is a p ...... sponse in tongue cancer cells.
@en
Epidermal growth factor is a p ...... sponse in tongue cancer cells.
@nl
type
label
Epidermal growth factor is a p ...... sponse in tongue cancer cells.
@ast
Epidermal growth factor is a p ...... sponse in tongue cancer cells.
@en
Epidermal growth factor is a p ...... sponse in tongue cancer cells.
@nl
prefLabel
Epidermal growth factor is a p ...... sponse in tongue cancer cells.
@ast
Epidermal growth factor is a p ...... sponse in tongue cancer cells.
@en
Epidermal growth factor is a p ...... sponse in tongue cancer cells.
@nl
P2093
P2860
P356
P1476
Epidermal growth factor is a p ...... sponse in tongue cancer cells.
@en
P2093
Adam Jedlinski
Ann-Charlotte Johansson
Anna Ansell
Karin Roberg
P2860
P356
10.1111/JOP.12310
P577
2016-01-01T00:00:00Z